Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1450
0.00 (0.00%)
Jul 15, 2026, 11:49 AM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 18.63 million as of July 14, 2026. Its market cap has decreased by -80.00% in one year.
Market Cap
18.63M
Enterprise Value
13.59M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has decreased from 19.02M to 18.63M, a decrease of -2.09%. That is a compound annual growth rate of -0.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 18.63M | -50.85% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Patrys | 26.66M |
| Noxopharm | 26.12M |
| Algorae Pharmaceuticals | 25.32M |
| NeuroScientific Biopharmaceuticals | 23.61M |
| Neurotech International | 21.08M |
| EZZ Life Science Holdings | 20.47M |
| Immuron | 14.05M |
| ReNerve | 13.78M |